583 related articles for article (PubMed ID: 26271592)
21. Multistimuli-Regulated Photochemothermal Cancer Therapy Remotely Controlled via Fe5C2 Nanoparticles.
Yu J; Ju Y; Zhao L; Chu X; Yang W; Tian Y; Sheng F; Lin J; Liu F; Dong Y; Hou Y
ACS Nano; 2016 Jan; 10(1):159-69. PubMed ID: 26602632
[TBL] [Abstract][Full Text] [Related]
22. Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy.
Zhi D; Yang T; Yang J; Fu S; Zhang S
Acta Biomater; 2020 Jan; 102():13-34. PubMed ID: 31759124
[TBL] [Abstract][Full Text] [Related]
23. Hydroxyl-modified magnetite nanoparticles as novel carrier for delivery of methotrexate.
Farjadian F; Ghasemi S; Mohammadi-Samani S
Int J Pharm; 2016 May; 504(1-2):110-6. PubMed ID: 26994523
[TBL] [Abstract][Full Text] [Related]
24. Nanoparticle-triggered release from lipid membrane vesicles.
Reimhult E
N Biotechnol; 2015 Dec; 32(6):665-72. PubMed ID: 25534673
[TBL] [Abstract][Full Text] [Related]
25. Magnetic Fe3O4-graphene composites as targeted drug nanocarriers for pH-activated release.
Fan X; Jiao G; Zhao W; Jin P; Li X
Nanoscale; 2013 Feb; 5(3):1143-52. PubMed ID: 23288110
[TBL] [Abstract][Full Text] [Related]
26. Open challenges in magnetic drug targeting.
Shapiro B; Kulkarni S; Nacev A; Muro S; Stepanov PY; Weinberg IN
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(3):446-57. PubMed ID: 25377422
[TBL] [Abstract][Full Text] [Related]
27. Magnetic Fe₃ O ₄ nanoparticles grafted with single-chain antibody (scFv) and docetaxel loaded β-cyclodextrin potential for ovarian cancer dual-targeting therapy.
Huang X; Yi C; Fan Y; Zhang Y; Zhao L; Liang Z; Pan J
Mater Sci Eng C Mater Biol Appl; 2014 Sep; 42():325-32. PubMed ID: 25063125
[TBL] [Abstract][Full Text] [Related]
28. Magnetically vectored platforms for the targeted delivery of therapeutics to tumors: history and current status.
Seeney C; Ojwang JO; Weiss RD; Klostergaard J
Nanomedicine (Lond); 2012 Feb; 7(2):289-99. PubMed ID: 22339137
[TBL] [Abstract][Full Text] [Related]
29. Superparamagnetic iron oxide nanoparticles (SPIONs)-loaded Trojan microparticles for targeted aerosol delivery to the lung.
Tewes F; Ehrhardt C; Healy AM
Eur J Pharm Biopharm; 2014 Jan; 86(1):98-104. PubMed ID: 24055690
[TBL] [Abstract][Full Text] [Related]
30. In vitro evaluation of biodegradable lignin-based nanoparticles for drug delivery and enhanced antiproliferation effect in cancer cells.
Figueiredo P; Lintinen K; Kiriazis A; Hynninen V; Liu Z; Bauleth-Ramos T; Rahikkala A; Correia A; Kohout T; Sarmento B; Yli-Kauhaluoma J; Hirvonen J; Ikkala O; Kostiainen MA; Santos HA
Biomaterials; 2017 Mar; 121():97-108. PubMed ID: 28081462
[TBL] [Abstract][Full Text] [Related]
31. Predicting DNA-mediated drug delivery in interior carcinoma using electromagnetically excited nanoparticles.
Ghosh S; Das T; Chakraborty S; Das SK
Comput Biol Med; 2011 Sep; 41(9):771-9. PubMed ID: 21752360
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
Kandasamy G; Maity D
Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
[TBL] [Abstract][Full Text] [Related]
33. Superparamagnetic iron oxide nanoparticulate system: synthesis, targeting, drug delivery and therapy in cancer.
Palanisamy S; Wang YM
Dalton Trans; 2019 Jul; 48(26):9490-9515. PubMed ID: 31211303
[TBL] [Abstract][Full Text] [Related]
34. MRI contrast variation of thermosensitive magnetoliposomes triggered by focused ultrasound: a tool for image-guided local drug delivery.
Lorenzato C; Cernicanu A; Meyre ME; Germain M; Pottier A; Levy L; de Senneville BD; Bos C; Moonen C; Smirnov P
Contrast Media Mol Imaging; 2013; 8(2):185-92. PubMed ID: 23281291
[TBL] [Abstract][Full Text] [Related]
35. A new magnetic nanocapsule containing 5-fluorouracil: in vivo drug release, anti-tumor, and pro-apoptotic effects on CT26 cells allograft model.
Shakeri-Zadeh A; Shiran MB; Khoee S; Sharifi AM; Ghaznavi H; Khoei S
J Biomater Appl; 2014 Oct; 29(4):548-56. PubMed ID: 24913615
[TBL] [Abstract][Full Text] [Related]
36. Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells.
Taratula O; Dani RK; Schumann C; Xu H; Wang A; Song H; Dhagat P; Taratula O
Int J Pharm; 2013 Dec; 458(1):169-80. PubMed ID: 24091153
[TBL] [Abstract][Full Text] [Related]
37. Bioactivity of Hybrid Polymeric Magnetic Nanoparticles and Their Applications in Drug Delivery.
Mohammed L; Ragab D; Gomaa H
Curr Pharm Des; 2016; 22(22):3332-52. PubMed ID: 26853596
[TBL] [Abstract][Full Text] [Related]
38. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
39. External magnetic fields affect the biological impacts of superparamagnetic iron nanoparticles.
Shanehsazzadeh S; Lahooti A; Hajipour MJ; Ghavami M; Azhdarzadeh M
Colloids Surf B Biointerfaces; 2015 Dec; 136():1107-12. PubMed ID: 26613856
[TBL] [Abstract][Full Text] [Related]
40. Drug-loaded gold/iron/gold plasmonic nanoparticles for magnetic targeted chemo-photothermal treatment of rheumatoid arthritis.
Kim HJ; Lee SM; Park KH; Mun CH; Park YB; Yoo KH
Biomaterials; 2015 Aug; 61():95-102. PubMed ID: 26001074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
